The EPS estimate of Ovascience Inc. (NASDAQ:OVAS) for quarter ended 2016-09-30 is $-0.82.
EPS projections 7 and 30 days ago were $-0.82 and $-0.82 respectively. Analysts projected $-0.82 and $-0.82 respectively as EPS 60 and 90 days ago. The projections shows a change of 0% from estimates of 7-days ago.
The EPS revisions up and down count in the preceding 7 days were 0 and 0 respectively. The count of bullish revisions in earnings in the last 1-month, 60, 90 and 120 days were 0, 0, 0 and 0.
The count of bearish revisions of EPS in the last 1-month, 60, 90 and 120 days were 0, 0, 1 and 0.
The count of EPS revisions bullish and bearish in the last 18 days were 0 and 0 respectively.
The EPS projection prior to the release of actual report for the period closed 1 is $-0.82 on basis of 3 EPS estimates. As on 2016-05-05, the reported EPS was $-0.8, showing a surprise of $-0.05 or -6.67%. It showed a standard deviation of 0.06.
Quarterly Sales Estimates
The arithmetic mean of released annual sales estimates for Ovascience Inc. (NASDAQ:OVAS) is $1.16 and the median is $1.16. The estimate is calculated by 2 analysts for the fiscal 2016.
The highest annual estimate is $2.12 and the lowest estimate is $0.2. The standard deviation of given annual sales estimates is 1.357%.
As many as 2 and 2 analysts have increased and decreased sales estimate, respectively in last seven days. It shows a percentage change of 0% from the past week.
Almost 2 and 2 analysts have increased and decreased sales estimate, respectively in last one month. It shows a percentage change of -15.513% from last month.
The number of analysts who have upped and decreased their sales projections in the last one-quarter is 2 and 2 respectively. The change in the estimate from last quarter is -40.816%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...